Last reviewed · How we verify

NCT06550440

The Impact of Family Integrated Care on Extrauterine Growth Restriction at Discharge in Very Low Birth Weight Infants

Completed Last updated 21 October 2024
What this trial tests

trial testing family integrated care in Very Low Birth Weight Infant in 1,255 participants. Completed in 1 May 2024.

Timeline
1 February 2021
Primary endpoint
30 November 2023
1 May 2024

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,255
Start date1 February 2021
Primary completion30 November 2023
Estimated completion1 May 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 28 Weeks to 32 Weeks, any sex, with Very Low Birth Weight Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the influence of multi-angle factors, including family integrated care, on extrauterine growth restriction at discharge of very low birth weight infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Very Low Birth Weight Infant

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06550440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing